Effective: December 26, 2011
Latest Legislation: House Bill 218 - 129th General Assembly
(A) No individual or group health insuring corporation policy, contract, or agreement that provides coverage for prescription drugs shall limit or exclude coverage for any drug approved by the United States food and drug administration on the basis that the drug has not been approved by the United States food and drug administration for the treatment of the particular indication for which the drug has been prescribed, provided the drug has been recognized as safe and effective for treatment of that indication in one or more of the standard medical reference compendia adopted by the United States department of health and human services under 42 U.S.C. 1395x(t)(2), as amended, or in medical literature that meets the criteria specified in division (B) of this section.
(B) Medical literature may be accepted for purposes of division (A) of this section only if all of the following apply:
(1) Two articles from major peer-reviewed professional medical journals have recognized, based on scientific or medical criteria, the drug's safety and effectiveness for treatment of the indication for which it has been prescribed;
(2) No article from a major peer-reviewed professional medical journal has concluded, based on scientific or medical criteria, that the drug is unsafe or ineffective or that the drug's safety and effectiveness cannot be determined for the treatment of the indication for which it has been prescribed;
(3) Each article meets the uniform requirements for manuscripts submitted to biomedical journals established by the international committee of medical journal editors or is published in a journal specified by the United States department of health and human services pursuant to Section 1861(t)(2)(B) of the "Social Security Act," 107 Stat. 591 (1993), 42 U.S.C. 1395 (x)(t)(2)(B), as amended, as accepted peer-reviewed medical literature.
(C) Coverage of a drug required by division (A) of this section includes medically necessary services associated with the administration of the drug.
(D) Division (A) of this section shall not be construed to do any of the following:
(1) Require coverage for any drug if the United States food and drug administration has determined its use to be contraindicated for the treatment of the particular indication for which the drug has been prescribed;
(2) Require coverage for experimental drugs not approved for any indication by the United States food and drug administration;
(3) Alter any law with regard to provisions limiting the coverage of drugs that have not been approved by the United States food and drug administration;
(4) Require reimbursement or coverage for any drug not included in the drug formulary or list of covered drugs specified in a health insuring corporation contract;
(5) Prohibit a health insuring corporation from limiting or excluding coverage of a drug, provided that the decision to limit or exclude coverage of the drug is not based primarily on the coverage of drugs required by this section.
(E) This section applies only to health insuring corporation policies, contracts, and agreements that are described in division (A) of this section and that are delivered, issued for delivery, or renewed in this state on or after July 1, 1997.
Structure Ohio Revised Code
Title 17 | Corporations-Partnerships
Chapter 1751 | Health Insuring Corporation Law
Section 1751.01 | Health Insuring Corporation Law Definitions.
Section 1751.02 | Applying for Certificate of Authority.
Section 1751.03 | Verification of Application.
Section 1751.04 | Review of Application and Documents by Superintendent.
Section 1751.05 | Issuance or Denial of Certificate of Authority.
Section 1751.06 | Powers Upon Obtaining Certificate.
Section 1751.07 | Responsibility for Funds.
Section 1751.08 | Inapplicability of Insurance Laws.
Section 1751.11 | Evidence of Coverage.
Section 1751.12 | Contractual Periodic Prepayment or Premium Rate.
Section 1751.13 | Contracts With Providers and Health Care Facilities.
Section 1751.14 | Termination of Coverage of Child.
Section 1751.18 | Cancelling or Failing to Renew Coverage.
Section 1751.19 | Complaint System.
Section 1751.20 | Unfair, Untrue, Misleading, or Deceptive Acts.
Section 1751.21 | Peer Review Committee.
Section 1751.25 | Investment of Funds.
Section 1751.26 | Investments in Real Estate.
Section 1751.27 | Deposit of Securities With Superintendent or Custodian.
Section 1751.271 | Medicaid Providers - Performance Bond.
Section 1751.31 | Changes in Corporation's Solicitation Document.
Section 1751.32 | Annual Report.
Section 1751.321 | Audit Report Filed Annually.
Section 1751.33 | Information to Be Provided to Subscribers.
Section 1751.34 | Examinations by Superintendent and Director.
Section 1751.35 | Suspension or Revocation of Certificate of Authority.
Section 1751.38 | Applicability of Other Laws.
Section 1751.40 | Insurance Companies Operating as Health Insuring Corporations.
Section 1751.42 | Rehabilitation, Liquidation, Supervision or Conservation of Corporation.
Section 1751.44 | Fees Paid to Superintendent of Insurance.
Section 1751.45 | Administrative Penalties - Violations.
Section 1751.46 | Recommendations for Expansion of Service Areas.
Section 1751.47 | Adopting Forms, Instructions and Manuals for Providing Financial Information.
Section 1751.51 | Restrictions on Choice of Providers.
Section 1751.52 | Confidentiality of Information.
Section 1751.521 | Medical Information Release.
Section 1751.53 | Continuing Coverage After Termination of Employment.
Section 1751.54 | Continuing Coverage After Reservist Called to Duty.
Section 1751.55 | Effect of Workers Compensation Coverage.
Section 1751.56 | Effect of Supplemental Sickness and Accident Insurance Policy.
Section 1751.57 | Conditions Applying to All Individual Health Insuring Corporation Contracts.
Section 1751.59 | Coverage of Adopted Children.
Section 1751.61 | Coverage for Newly Born Child.
Section 1751.62 | Screening Mammography - Cytologic Screening for Cervical Cancer.
Section 1751.63 | Long-Term Care Insurance.
Section 1751.65 | Health Insuring Corporation - Prohibited Activities.
Section 1751.66 | Prescription Drugs.
Section 1751.67 | Maternity Benefits.
Section 1751.68 | Provisions for Medication Synchronization for Enrollees.
Section 1751.70 | Authorization of Payroll Deductions for Public Employees.
Section 1751.71 | Accepting Payments for Cost of Policies, Contracts, and Agreements.
Section 1751.72 | Policy, Contract, or Agreement Containing a Prior Authorization Requirement.
Section 1751.73 | Implementing Quality Assurance Programs.
Section 1751.74 | Quality Assurance Program Requirements.
Section 1751.75 | Determination That Accreditation Constitutes Compliance.
Section 1751.77 | Utilization Review, Internal and External Review Procedure Definitions.
Section 1751.78 | Application of Provisions.
Section 1751.79 | Utilization Review Program Requirements.
Section 1751.80 | Implementing Utilization Review Programs.
Section 1751.811 | Internal and External Reviews.
Section 1751.82 | Reconsideration of Adverse Determination.
Section 1751.821 | Determination That Accreditation Constitutes Compliance.
Section 1751.822 | Cooperation With Utilization Review Program.
Section 1751.823 | Filing Certificate of Compliance.
Section 1751.83 | Maintaining Internal Review System.
Section 1751.84 | Coverage for Autism Spectrum Disorder.
Section 1751.85 | Information for Vision Care Services or Materials.
Section 1751.86 | Violation Deemed Unfair and Deceptive Act or Practice.
Section 1751.87 | Cause of Action Not Created.
Section 1751.89 | Medicare and Medicaid Exceptions.
Section 1751.90 | Coverage for Teledentistry.
Section 1751.91 | Reimbursement for Pharmacists Providing Health Care.